yes, I think they run phase 2 and 3 along together, meaning they can start phase 3 before they finish phase 2. Hottod does mention that indirectly, but you cant shave too much time off because they wont let you start phase 3 until you get good results in the beginning of phase 2. And Phase 3 is the longest as you need 2 years of data to prove things inconclusively. But with slowly developing blindness there is not as much hurry as there is with cancer, so we wouldn’t be given the green light as fast as an oncology drug. So revenue hinges off phase 3 and drug approval/sales, but the rerate will hinge off efficacy. Who knows when the market will be given that tick.
- Forums
- ASX - By Stock
- PYC
- New valuation of PYC
New valuation of PYC, page-14
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $559.9M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 12.0¢ | $279.9K | 2.315M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 147929 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 834773 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 147929 | 0.120 |
13 | 978136 | 0.115 |
11 | 663187 | 0.110 |
13 | 1606450 | 0.105 |
15 | 1401739 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 834773 | 5 |
0.130 | 397621 | 3 |
0.135 | 750295 | 4 |
0.140 | 756230 | 8 |
0.145 | 443572 | 9 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |